Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose


It remains unclear why the dose of xanthine oxidase inhibitors (XOI) allopurinol or febuxostat varies among patients though they reach similar serum uric acid (SUA) goal. We pursued genomic sequencing of XOI metabolism and clearance genes to identify single-nucleotide polymorphisms (SNPs) relate to differences in XOI dose. Subjects with a diagnosis of Gout… (More)
DOI: 10.1007/s00296-016-3592-2

6 Figures and Tables


  • Presentations referencing similar topics